Evidence map›Paper›PMID 38399464›Full record

ArticlePharmaceuticals (Basel, Switzerland)2024

Disposition of Hexahydrocannabinol Epimers and Their Metabolites in Biological Matrices following a Single Administration of Smoked Hexahydrocannabinol: A Preliminary Study.

Annagiulia Di Trana, Alessandro Di Giorgi, Giorgia Sprega, Jeremy Carlier, Giorgi Kobidze, Eva Montanari, Omayema Taoussi, Giulia Bambagiotti, Maria Sofia Fede, Alfredo Fabrizio Lo Faro and 3 more

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Dissociative-like Neurotoxicity Following Analytically Confirmed Exposure To Hexahydrocannabinol (HHC).Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2026
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Annagiulia Di TranaNational Centre on Addiction and Doping, National Institute of Health, 00161 Rome, Italy.
Alessandro Di GiorgiDepartment of Biomedical Sciences and Public Health, University "Politecnica delle Marche", 60126 Ancona, Italy.
Giorgia SpregaDepartment of Biomedical Sciences and Public Health, University "Politecnica delle Marche", 60126 Ancona, Italy.
Jeremy CarlierDepartment of Biomedical Sciences and Public Health, University "Politecnica delle Marche", 60126 Ancona, Italy.ORCID 0000-0003-3332-9518
Giorgi KobidzeDepartment of Biomedical Sciences and Public Health, University "Politecnica delle Marche", 60126 Ancona, Italy.
Eva MontanariDepartment of Biomedical Sciences and Public Health, University "Politecnica delle Marche", 60126 Ancona, Italy.ORCID 0000-0003-0044-1714
Omayema TaoussiDepartment of Biomedical Sciences and Public Health, University "Politecnica delle Marche", 60126 Ancona, Italy.
Giulia BambagiottiDepartment of Biomedical Sciences and Public Health, University "Politecnica delle Marche", 60126 Ancona, Italy.
Maria Sofia FedeDepartment of Biomedical Sciences and Public Health, University "Politecnica delle Marche", 60126 Ancona, Italy.
Alfredo Fabrizio Lo FaroDepartment of Biomedical Sciences and Public Health, University "Politecnica delle Marche", 60126 Ancona, Italy.ORCID 0000-0002-0240-5277
Anastasio TiniDepartment of Biomedical Sciences and Public Health, University "Politecnica delle Marche", 60126 Ancona, Italy.
Francesco Paolo BusardòDepartment of Biomedical Sciences and Public Health, University "Politecnica delle Marche", 60126 Ancona, Italy.
Simona PichiniNational Centre on Addiction and Doping, National Institute of Health, 00161 Rome, Italy.
Marche Polytechnic University · ITNational Centre for Disease Prevention and Control · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2023, hexahydrocannabinol (HHC) attracted the attention of international agencies due to its rapid spread in the illegal market. Although it was discovered in 1940, less is known about the pharmacology of its two naturally occurring epimers, 9(R)-HHC and 9(S)-HHC. Thus, we aimed to investigate the disposition of hexahydrocannabinol epimers and their metabolites in whole blood, urine and oral fluid following a single controlled administration of a 50:50 mixture of 9(R)-HHC and 9(S)-HHC smoked with tobacco. To this end, six non-user volunteers smoked 25 mg of the HHC mixture in 500 mg of tobacco. Blood and oral fluid were sampled at different time points up to 3 h after the intake, while urine was collected between 0 and 2 h and between 2 and 6 h. The samples were analyzed with a validated HPLC-MS/MS method to quantify 9(R)-HHC, 9(S)-HHC and eight metabolites. 9(R)-HHC showed the highest C

Indexed as

biological matriceshexahydrocannabinol epimersHHC metabolitespharmacokinetics

Identifiers

PMID38399464
PMCPMC10892555
OpenAlexW4391840473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.